Researchers in Japan have developed a new method to track cell-to-cell interactions.
A study published in Cell Reports Methods by The University of Osaka describes the development of novel fluorescent markers designed for monitoring cell communication under a microscope.
Overcoming Limitations of Traditional Tracking
Traditional methods for visualizing cell contacts often use green fluorescent protein (GFP). Split GFP, a common marker, involves two halves expressed on different cells that recombine and fluoresce upon stable contact. While effective for detecting stable connections, its slow signal emission and irreversible nature limit its ability to track dynamic, real-time cell interactions.
Introducing Gachapin: A Rapid-Acting Solution
To address this limitation, the researchers developed a new fluorescent marker named Gachapin. Gachapin consists of two parts: a fluorescent component that remains dark until it is in close proximity to its binding partner, and a binding component that activates the fluorescent part.
This design enables Gachapin to illuminate rapidly when cells make contact and deactivate when they separate, facilitating the detection of temporary and reversible cell-cell interactions.
Using time-lapse imaging with Gachapin, researchers observed neuronal processes forming contacts with adjacent neurons in real-time.
Gachapin-C: Single-Component Versatility
Additionally, a single-component version called Gachapin-C was developed. When expressed in neurons, Gachapin-C fluoresced upon contact between different cells and also when processes from the same neuron interacted.
Enhancing Understanding of Cellular Connectivity
These indicators, Gachapin and Gachapin-C, are expected to enhance the visualization and understanding of cellular interactions. The study suggests that these rapid-acting fluorescent indicators can monitor complex connectivity patterns across various cell types, including neurons.
Future applications include advancing neural circuit research and clarifying the role of dynamic cellular interactions in brain disorders, which could contribute to the development of new treatments.